UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000037212 |
|---|---|
| Receipt number | R000042428 |
| Scientific Title | Analysis of serum peptide profile of relapsing polychondritis |
| Date of disclosure of the study information | 2019/07/01 |
| Last modified on | 2020/08/04 14:27:19 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Comprehensive analysis of serum peptides from patients with relapsing polychondritis
Acronym
Analysis of serum peptides of relapsing polychondritis
Scientific Title
Analysis of serum peptide profile of relapsing polychondritis
Scientific Title:Acronym
Serum peptidomics of relapsing polychondritis
Region
| Japan |
Condition
Condition
relapsing polychondritis, rheumatoid arthritis, granulomatosis with polyangiitis, healthy condition
Classification by specialty
| Clinical immunology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To detect serum peptides which are biomarker candidates for relapsing polychondritis
Basic objectives2
Others
Basic objectives -Others
To detect serum peptides associated with the pathophysiology of relapsing polychondritis
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Diiference of serum peptide ion intensity between relapsing polychondritis and the control diseases/healthy condition
Key secondary outcomes
Identification of amino acid sequences and parent proteins of the above serum peptides
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients diagnosed with relapsing polychondritis, rheumatoid arthritis, or granulomatosis with polyangiitis in St. Marianna university hospital. Healthy volunteers who wark in St. Marianna university or St. Marianna university hospital.
Key exclusion criteria
Patients with moderate or severe levels of anemia.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Manae |
| Middle name | Suzuki |
| Last name | Kurokawa |
Organization
St. Marianna University Graduate School of Medicine
Division name
Disease Biomarker Analysis and Molecular Regulation
Zip code
216-8511
Address
2-16-1, Sugao, Miyamae-ku, Kawasaki
TEL
81-44-977-8111
manae@marianna-u.ac.jp
Public contact
Name of contact person
| 1st name | Manae |
| Middle name | Suzuki |
| Last name | Kurokawa |
Organization
St. Marianna University Graduate School of Medicine
Division name
Disease Biomarker Analysis and Molecular Regulation
Zip code
216-8511
Address
2-16-1, Sugao, Miyamae-ku, Kawasaki
TEL
81-44-977-8111
Homepage URL
manae@marianna-u.ac.jp
Sponsor or person
Institute
St. Marianna University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
St. Marianna University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Division of Graduate Student Affairs and Research Promotion
Address
2-16-1, Sugao, Miyamae-ku, Kawasaki
Tel
81-44-977-8111
k-sienbu.mail@marianna-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 07 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Suspended
Date of protocol fixation
| 2018 | Year | 01 | Month | 10 | Day |
Date of IRB
| 2018 | Year | 02 | Month | 09 | Day |
Anticipated trial start date
| 2018 | Year | 02 | Month | 10 | Day |
Last follow-up date
| 2023 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We extract serum peptides by weak cation exchange and comprehensively analyze their ion intensity by mass spectrometry.
Management information
Registered date
| 2019 | Year | 06 | Month | 30 | Day |
Last modified on
| 2020 | Year | 08 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042428
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
